NCT03849677

Brief Summary

50 vegans and 50 omnivores will be recruited at the Erasme Hospital, Brussels. Hypothesis

  • Relative induced-hyperuricemia by the vegan diet is not associated with impaired endothelial function if vitamin B12 and folic acid levels are normal.
  • Quantification of xanthine oxidoreductase (XOR) isoforms varies according to the diet. Omnivores present more xanthine oxidase (XO) than vegans in which the xanthine dehydrogenase (XD) isoform is more prevalent.
  • The vegan group has more favorable oxidant, metabolic and inflammatory profiles than the omnivore group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
103

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 6, 2019

Completed
15 days until next milestone

First Posted

Study publicly available on registry

February 21, 2019

Completed
17 days until next milestone

Study Start

First participant enrolled

March 10, 2019

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 20, 2020

Completed
Last Updated

July 1, 2020

Status Verified

June 1, 2020

Enrollment Period

1.1 years

First QC Date

February 6, 2019

Last Update Submit

June 29, 2020

Conditions

Keywords

uric acidhemodynamic parametersendothelial functionoxidative stress and inflammationveganomnivore

Outcome Measures

Primary Outcomes (1)

  • Measure of the perfusion of the microcirculation of the skin

    Endothelial function assessment will be performed through analyse of the perfusion of the microcirculation of the skin in the forearm will be assessed by means of a laser Doppler imager and iontophoresis of acetylcholine and sodium nipride. Heating-induced hyperemia will be assessed after iontophoresis of inhibitor of NO synthase and saline. Units are perfusion unit. Iontophoresis is a non-invasive tool which permits to infuse molecules in the first micrometers of the skin. The used molecules are vasodilative, saline or NO synthase inhibitor.

    2 hours

Secondary Outcomes (18)

  • Concentration of Uric acid

    2 hours

  • Concentration of xanthine oxidase and xanthine dehydrogenase in blood

    2 hours

  • Measure of hemoglobin

    2 hours

  • Measure of white blood cells, red blood cells and platelets

    2 hours

  • Measure of urea, creatinine, bilirubin, albumine, prealbumin, LDL, HDL, lp(a), total cholesterol, triglyceride, apolipoprotein A and B

    2 hours

  • +13 more secondary outcomes

Study Arms (2)

Omnivore

Other: Endothelial function and inflammation

Vegan

Other: Endothelial function and inflammation

Interventions

Analysis of endothelial function, oxidative stress

OmnivoreVegan

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Participants will be recruited upon invitation on social network mainly.

You may qualify if:

  • Vegan or omnivore diet for at least one year (matched for age, gender, BMI, socio-economic status and weight)
  • Healthy

You may not qualify if:

  • Smoking
  • Chronic treatment
  • No allowed drugs taking
  • Excessive alcohol consumption

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Erasme Hospital

Brussels, Belgique, 1070, Belgium

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood and urine

MeSH Terms

Conditions

Inflammation

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 6, 2019

First Posted

February 21, 2019

Study Start

March 10, 2019

Primary Completion

March 30, 2020

Study Completion

June 20, 2020

Last Updated

July 1, 2020

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will not share

Locations